Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025)
Protagonist Therapeutics (PTGX) reported Non-Current Deffered Revenue of $2.8 million for Q3 2025, down 83.11% on a YoY basis from $16.5 million in Q3 2024, and down 48.13% sequentially from $5.4 million in Q2 2025.
Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends
Protagonist Therapeutics (PTGX) has 6 years of Non-Current Deffered Revenue data on file, last reported at $2.8 million in Q3 2025.
- For the quarter ending Q3 2025, Non-Current Deffered Revenue fell 83.11% year-over-year to $2.8 million; the trailing twelve-month figure through Sep 2025 stood at $2.8 million (down 83.11% YoY), and the FY2024 full-year result was $11.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue eased to $2.8 million in Q3 2025, from $5.4 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $28.9 million in Q1 2024 to a low of $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 8.18 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Sep 30, 2024 | 16.51 Mn |
| Jun 30, 2024 | 20.76 Mn |
| Mar 31, 2024 | 28.92 Mn |
| Sep 30, 2020 | 4.11 Mn |
| Jun 30, 2020 | 16.78 Mn |
| Mar 31, 2020 | 20.42 Mn |
| Dec 31, 2019 | 23.79 Mn |
| Sep 30, 2019 | 22.20 Mn |
| Jun 30, 2019 | 23.85 Mn |
| Dec 31, 2018 | 799,000.00 |
| Sep 30, 2018 | 797,000.00 |
| Jun 30, 2018 | 793,000.00 |
| Mar 31, 2018 | 694,000.00 |
| Dec 31, 2017 | 547,000.00 |
| Sep 30, 2017 | 332,000.00 |
| Jun 30, 2017 | 83,000.00 |